Stability of canine pancreatic lipase immunoreactivity concentration in serum samples and effects of long-term administration of prednisone to dogs on serum canine pancreatic lipase immunoreactivity concentrations.
OBJECTIVE
To evaluate stability of canine pancreatic lipase immunoreactivity (cPLI) in serum samples and to determine the effect of long-term administration of prednisone on serum cPLI concentrations.


METHODS
8 canine serum samples for the stability evaluation and serum samples obtained from 6 healthy young adult heterozygous (carrier) dogs with X-linked hereditary nephritis for determining the effect of prednisone administration.


METHODS
To evaluate stability of serum cPLI concentration, an aliquot of each serum sample was stored at each of 4 temperatures between -80 degrees and 24 degrees C; samples were analyzed on days 0, 3, 7, 14, and 21. To determine the effect of long-term prednisone administration, pretreatment serum samples were obtained (days 0 and 14) and prednisone was administered (2.2 mg/kg, q 24 h, PO) on days 15 through 42, with serum samples obtained on days 28 and 42. Additional serum samples were obtained on days 56 and 70.


RESULTS
Mean serum cPLI concentrations did not change significantly from day 0 to day 21 regardless of storage temperature. Serum cPLI concentrations in dogs after prednisone administration were within the reference range for all dogs at all time points, and results of repeated-measures ANOVA revealed that serum cPLI concentrations did not change significantly over time.


CONCLUSIONS
Serum cPLI concentrations measured in canine serum samples stored at room temperature, in a refrigerator, or in a freezer at -20 degrees or -80 degrees C were stable for at least 21 days. Also, long-term prednisone administration to dogs did not significantly affect serum cPLI concentrations.
Steiner
Jörg M
JM
Gastrointestinal Laboratory, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX 77843, USA.
Teague
Sheila R
SR
Lees
George E
GE
Willard
Michael D
MD
Williams
David A
DA
Ruaux
Craig G
CG
D000704:Analysis of Variance; D000818:Animals; D004285:Dogs / Q000097:blood*; D004305:Dose-Response Relationship, Drug; D008049:Lipase / Q000097:blood* / Q000276:immunology*; D010179:Pancreas / Q000201:enzymology*; D011241:Prednisone / Q000008:administration & dosage / Q000494:pharmacology*; D013696:Temperature
D008049:Lipase; D011241:Prednisone